(IBTM) iShares iBonds Dec 2032 - Ratings and Ratios
US Treasury Securities, Government Bonds, Fixed Income
Description: IBTM iShares iBonds Dec 2032
The iShares iBonds Dec2032 Term Treasury ETF (NASDAQ:IBTM) is a target maturity ETF that tracks a market value-weighted index of U.S. Treasury securities, with a focus on securities that will mature in December 2032. The index is constructed by reducing the amounts outstanding by the amounts held by the Federal Reserve SOMA, providing a more accurate representation of the available market.
The funds investment strategy is to invest at least 80% of its assets in the component securities of the index, and at least 90% of its assets in U.S. Treasury securities that are expected to help the fund track the index. This approach is designed to provide a high degree of tracking accuracy, except during the final months of the funds operations.
From a performance perspective, key metrics to consider include the funds yield, duration, and credit quality. Given the funds focus on U.S. Treasury securities, credit quality is likely to be extremely high. The funds duration is likely to be closely matched to the maturity date of December 2032, providing a clear indication of the funds interest rate risk. Investors should also consider the funds expense ratio, which is likely to be relatively low given the funds passive management strategy.
In terms of key performance indicators (KPIs), investors may want to monitor the funds tracking error, yield to maturity, and average duration. A low tracking error would indicate that the fund is effectively replicating the performance of the underlying index. The yield to maturity would provide a clear indication of the funds expected return, while the average duration would provide insight into the funds sensitivity to changes in interest rates.
IBTM ETF Overview
Market Cap in USD | 330m |
Category | Target Maturity |
TER | 0.07% |
IPO / Inception | 2022-07-06 |
IBTM ETF Ratings
Growth Rating | 43.4% |
Fundamental | - |
Dividend Rating | 66.0% |
Return 12m vs S&P 500 | -14.0% |
Analyst Rating | - |
IBTM Dividends
Dividend Yield 12m | 3.92% |
Yield on Cost 5y | 4.08% |
Annual Growth 5y | 40.34% |
Payout Consistency | 100.0% |
Payout Ratio | % |
IBTM Growth Ratios
Growth Correlation 3m | 86.3% |
Growth Correlation 12m | 66.8% |
Growth Correlation 5y | 54.4% |
CAGR 5y | 3.24% |
CAGR/Max DD 3y | 0.32 |
CAGR/Mean DD 3y | 1.16 |
Sharpe Ratio 12m | -0.74 |
Alpha | 0.00 |
Beta | 0.995 |
Volatility | 5.35% |
Current Volume | 255.7k |
Average Volume 20d | 87.8k |
Stop Loss | 22.5 (-3.4%) |
Signal | -0.25 |
What is the price of IBTM shares?
Over the past week, the price has changed by +0.22%, over one month by +2.03%, over three months by +3.85% and over the past year by +2.16%.
Is iShares iBonds Dec 2032 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTM is around 22.03 USD . This means that IBTM is currently overvalued and has a potential downside of -5.41%.
Is IBTM a buy, sell or hold?
What are the forecasts/targets for the IBTM price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.8 | 6.6% |
Last update: 2025-09-05 04:46
IBTM Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.16
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 330.0m USD (330.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 330.0m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 330.0m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(330.0m)/V(0.0) * Re(9.68%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle